Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal bupivacaine 10 mg versus 12 mg for repeated spinal anesthesia after failed spinal anesthesia in cesarean section
IRCT20120915010841N20Phase 2Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of bupivacaine in None (2 arms), sponsored by Hamadan University of Medical Sciences. Primary endpoints: sensory block and postdural puncture headache. Started Jun 2018; status: completed.
02
Drugs
bupivacaine
Beyond the preview
Go deeper on IRCT20120915010841N20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120915010841N20.